Optimal cancer drug dosing in adolescents: new issues and the old unaddressed ones-Reference-Cited by-同舟云学术

Optimal cancer drug dosing in adolescents: new issues and the old unaddressed ones

Published:2018-09 Issue:9 Volume:48 Page:1023-1027
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Ryan Jessica¹^ORCID,Patel Joanne,Lucas Catherine J.,Martin Jennifer H.^ORCID

Affiliation:

1. Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Level 3 Hunter Medical Research Institute, and Hunter New England Local Health District; Kookaburra Circuit; Newcastle New South Wales Australia

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.14020/fullpdf

Reference28 articles.

1. Adolescent and young adult cancer: a revolution in evolution?;Thomas;Intern Med J,2006

2. Children versus adults: pharmacokinetic and adverse-effect differences;Anderson;Epilepsia,2002

3. Developmental pharmacokinetics in pediatric populations;Lu;J Pediatr Pharmacol Ther,2014

4. Factors and mechanisms for pharmacokinetic differences between paediatric population and adults;Fernandez;Pharmaceutics,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data;International Journal of Cancer;2023-10-20

2. The rationale of dose–response curves in selecting cancer drug dosing;British Journal of Clinical Pharmacology;2019-06-20